2 major FDA rejections leave some pharma investors worried about intensification of regulations

2 major FDA rejections leave some pharma investors worried about intensification of regulations

Source: 
Beckers Hospital Review
snippet: 

Investors looking to do business in the pharmaceutical industry should beware that drug development is an uncertain process that could take a long time before becoming profitable, according to The Wall Street Journal.